Determination of ng/mL levetiracetam using ultra-high-performance liquid chromatography-photodiode absorbance

Journal of Chromatographic Science

Volumn 50, Issue 3, 2012, Pages 253-258

  Olah E ^a   Bacsói, Gy ^b   Fekete, J ^a   Sharma, V K ^c  

^a BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS   (Hungary)

^b National Institute of Neuroscience   (Hungary)

^c Florida Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; ETIRACETAM; PIRACETAM; PLASMA PROTEIN;

ARTICLE; BLOOD; CHEMISTRY; EPILEPSY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; LIQUID LIQUID EXTRACTION; METHODOLOGY; PH; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; STATISTICAL MODEL; TEMPERATURE;

BLOOD PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPILEPSY; HUMANS; HYDROGEN-ION CONCENTRATION; LIMIT OF DETECTION; LINEAR MODELS; LIQUID-LIQUID EXTRACTION; PIRACETAM; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; TEMPERATURE;

EID: 84859930678     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/bmr053     Document Type: Article

References (21)

1. Gambardella, A.; Labate, A.; Colosimo, E.; Ambrosio, R.; Quattrone, A. Monotherapy for partial epilepsy: Focus on Levetiracetam. Neuropsychiatric Disease and Treatment 2008, 4, 33-38.
2. Patsalos, P.N. Clinical pharmacokinetics of Levetiracetam. Clinical Pharmacokinetics 2004, 43, 707-724.
3. Radtke, R.A. Pharmacokinetics of Levetiracetam. Epilesia 2001, 45, 24-27.
4. Tong, X.; Patsalos, P.N. A microdialysis study of the novel antiepilep-tic drug Levetiracetam: Extracellular pharmacokinetics and effect on taurine in rat brain. British Journal of Pharmacology 2001, 133, 867-874.
5. Isoherranen, N.; Yagen, B.; Soback, S.; Roeder, M.; Schurig, V.; Bialer, M. Pharmacokinetics of Levetiracetam and its enantiomer (R)-a-ethyl-2-oxo- pyrrolidine acetamide in dogs. Epilepsia 2001, 42, 825-830.
6. Contin, M.; Mohamed, S.; Albani, F.; Riva, R.; Baruzzi, A. Simple and validated HPLC-UV analysis of Levetiracetam in deproteinized plasma of patients with epilepsy. Journal of Chromatography, B: Biomedical Sciences and Applications 2008, 873, 129-132.
7. Martens-Lobenhoffer, J.; Bode-Boger, S.M. Determination of Levetiracetam in human plasma with minimal sample pretreatment. Journal of Chromatography B 2005, 819, 197-200.
8. Pucci, V.; Bugamelli, F.; Mandrioli, R.; Ferranti, A.; Kenndler, E.; Raggi, M.A. High-performance liquid chromatographic determination of Levetiracetam in human plasma: Comparison of different sample clean-up procedures. Biomedical Chromatography 2004, 18, 37-44.
9. Shihabi, Z.K.; Oles, K.; Hinsdale, M.; Analysis of antiepileptic drug Keppra by capillary electrophoresis. Journal of Chromatography A 2003, 1004, 9-12.
10. Matar, K.M. Quantification of Levetiracetam in human plasma by liquid chromatography-tandem mass spectrometry: Application to therapeutic drug monitoring. Journal of Pharmaceutical and Biomedical Analysis 2008, 48, 822-828.
11. Guo, T.; Oswald, L.M.; Mendu, D.R.; Soldin, S.J. Determination of Levetiracetam in human plasma/serum/saliva by liquid chromatography-electrospray tandem mass spectrometry. Clinica Chimica Acta 2007, 375, 115-118.
12. Rao, B.M.; Ravi, R.; Reddy, B.S.S.; Sivakumar, S.; Chand, I.G.; Kumar, K.P., etc. A validated chiral LC method for the enantioselective analysis of Levetiracetam and its enantiomer R-a-ethyl-2-oxo-pyrrolidine aceta-mide on amylase-based stationary phase. Journal of Pharmaceutical and Biomedical Analysis 2004, 35, 1017-1026.
13. Isoherranen, N.; Roeder, M.; Soback, S.; Yagen, B.; Schurig, V.; Bialer, M. Enantioselective analysis of Levetiracetam and its enantiomer R-a-ethyl-oxo-pyrrolidine acetamide using gas chromatography and ion trap mass spectrometric detection. Journal of Chromatography B: Biomedical Sciences and Applications 2000, 745, 325-332.
14. Blonk, M.I.; van der Nagel, B.C.; Smit, L.S.; Mathot, R.A.A. Quantification of Levetiracetam in plasma of neonates by ultra performance liquid chromatography-tandem mass spectrometry. Journal of Chromatography B 2010, 878, 675-681.
15. Novakova, L.; Vlckova, H. A review of current trends and advances in modern bio-analytical methods: Chromatography and preparation. Analytica Chimica Acta 2009, 656, 8-35.
16. Swartz, M.E. HPLC method development for pharmaceuticals, Vol. 8, 1st ed. Ahuja, S.; Rasmussen, H. (eds.), Elsevier Italy 2007, pp. 145-186.
17. de Villiers, A.; Lestremau, F.; Szucs, R.; Gelebart, S.; David, F.; Sandra, P. Evaluation of ultra performance liquid chromatography Part I. Possibilities and limitations. Journal of Chromatography A 2006, 1127, 60-69.
18. Nguyen, D.T.-T.; Guillarme, D.; Rudaz, S.; Veuthey, J.-L. Chromatographic behaviour and comparison of column packed with sub-2 mm stationary phases in liquid chromatography. Journal of Chromatography A 2006, 1128, 105-113.
19. Shabir, G.A. Validation of high-performance liquid chromatography methods for pharmaceutical analysis. Understanding the differences and similarities between validation requirements of the US Food and Drug Administration, the US Pharmacopeia and International Conference on Harmonization; Journal of Chromatography A 2003, 987, 57-66.
20. ICH Topic Q2B, Validation of Analytical procedures: Methodology (CMP/ICH/281/95). Step 4. Consensus Guideline, The European Agency for Evaluation of Medicinal Products, 1996.
21. International Conference of Harmonization (ICH), Q2A: Text of Validation of Analytical Procedures, US FDA Federal Register, Vol. 60, 1995, p. 11260.